PI: Jiayi Huang, MD
WU201901009 | NCT03604978
Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma
PI: Jiayi Huang, MD
WU202206033 | NCT05095376
Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
PI: Tanner Johanns, PhD
WU202012180 | NCT04145115
Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma
PI: Jiayi Huang, MD
WU202205105 | NCT05393258
Pilot Study of Temporally-modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-mutant Gliomas After Prior External Beam Radiation Therapy
PI: Tanner Johanns, PhD
WU202204150 | NCT05362409
Phase I Multi-center Clinical Trial Evaluating the Safety and Tolerability of 5-aminolevulinic Acid Combined with CV01 Delivery of Ultrasound for Sonodynamic Therapy in Patients with Recurrent High Grade Glioma
PI: Milan Chheda, MD
201810185 | NCT03687957
Effect of rhIL-7-hyFc on increasing lymphocyte counts in patients with newly diagnosed non-severe lymphopenic gliomas following radiation and temozolomide
PI: Milan Chheda, MD
202011112 | NCT03173950
Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients with Recurrent Select Rare CNS Cancers